{
  "cutoff": "2026-10-09",
  "note": "Selected publication milestones, not an exhaustive history or priority-of-discovery determination.",
  "milestones": [
    {
      "year": "1999",
      "pmid": "10089885",
      "doi": "10.1016/s0092-8674(00)80580-2",
      "title": "Longevity, stress response, and cancer in aging telomerase-deficient mice.",
      "interpretation": "Telomerase-null mouse stress and lifespan phenotypes; restricted genetic model.",
      "url": "https://pubmed.ncbi.nlm.nih.gov/10089885/"
    },
    {
      "year": "2007",
      "pmid": "17143283",
      "doi": "10.1038/ng1937",
      "title": "Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation.",
      "interpretation": "Checkpoint p21 manipulation dissociates persistent telomere dysfunction from some tissue and survival effects.",
      "url": "https://pubmed.ncbi.nlm.nih.gov/17143283/"
    },
    {
      "year": "2011",
      "pmid": "21113150",
      "doi": "10.1038/nature09603",
      "title": "Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice.",
      "interpretation": "Endogenous reactivation rescues a telomerase-deficiency model.",
      "url": "https://pubmed.ncbi.nlm.nih.gov/21113150/"
    },
    {
      "year": "2012",
      "pmid": "22585399",
      "doi": "10.1002/emmm.201200245",
      "title": "Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer.",
      "interpretation": "AAV-TERT tests intervention in adult and old mice.",
      "url": "https://pubmed.ncbi.nlm.nih.gov/22585399/"
    },
    {
      "year": "2019",
      "pmid": "31444995",
      "doi": "10.1111/acel.13017",
      "title": "Telomere length and aging-related outcomes in humans: A Mendelian randomization study in 261,000 older participants.",
      "interpretation": "Human genetic contrasts expose cardiovascular/cancer trade-offs.",
      "url": "https://pubmed.ncbi.nlm.nih.gov/31444995/"
    },
    {
      "year": "2024",
      "pmid": "38908367",
      "doi": "10.1016/j.cell.2024.05.048",
      "title": "TERT activation targets DNA methylation and multiple aging hallmarks.",
      "interpretation": "Pharmacological TERT activation improves selected aged-mouse functions; mechanism separation remains open.",
      "url": "https://pubmed.ncbi.nlm.nih.gov/38908367/"
    }
  ],
  "gaps": [
    "Mean LTL does not measure the critical shortest telomeres in every aging tissue.",
    "Human telomerase-activator biomarker effects lack demonstrated ordinary-aging functional benefit.",
    "Canonical telomere maintenance versus noncanonical TERT effects require selective separation.",
    "Cancer initiation, genomic instability and regenerative failure create endpoint-specific trade-offs.",
    "Independent ordinary-aging replication and longer functional/cancer follow-up are needed."
  ],
  "decisive_experiment": "A randomized prospectively registered trial in older adults without telomere disorders, with tissue-specific critical-short-telomere engagement, a selective maintenance intervention and orthogonal mechanism controls, prespecified functional healthspan endpoints and sufficiently long cancer surveillance. Preclinical epistasis should first separate canonical telomere effects from noncanonical TERT actions."
}